[{"AccountsPayableCurrent_0_Q3_USD":2752000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":980000.0,"PaymentsToAcquireInvestments_3_Q3_USD":10000000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":17000.0,"PaymentsForRepurchaseOfCommonStock_3_Q3_USD":9014000.0,"PaymentsForRepurchaseOfCommonStock_1_Q3_USD":5100000.0,"OtherPrepaidExpenseCurrent_0_Q3_USD":228000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":211000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":68000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-94000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-26000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-26000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_3_Q3_USD":-94000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":110000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.0451,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"OperatingLeaseRightOfUseAsset_0_Q3_USD":3093000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":3973000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":278000.0,"OperatingLeaseLiability_0_Q3_USD":4251000.0,"OperatingLeaseCost_3_Q3_USD":272000.0,"OperatingLeaseCost_1_Q3_USD":108000.0,"OperatingIncomeLoss_3_Q3_USD":39643000.0,"OperatingIncomeLoss_1_Q3_USD":14004000.0,"NetIncomeLoss_3_Q3_USD":30173000.0,"NetIncomeLoss_1_Q3_USD":10329000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":41196000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-10980000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":-5617000.0,"LongTermInvestments_0_Q3_USD":0.0,"LiabilitiesCurrent_0_Q3_USD":20614000.0,"OperatingLeasePayments_3_Q3_USD":29000.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":107476175.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":107843196.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_3_Q3_shares":4005413.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q3_shares":4646646.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q3_USD":0.0,"TreasuryStockAcquiredAverageCostPerShare_3_Q3_USD":5.15,"TreasuryStockAcquiredAverageCostPerShare_1_Q3_USD":5.32,"StockRepurchasedDuringPeriodValue_1_Q3_USD":5053000.0,"StockRepurchasedDuringPeriodShares_3_Q3_shares":1749746.0,"StockRepurchasedDuringPeriodShares_1_Q3_shares":949746.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":2955000.0,"StockholdersEquity_0_Q3_USD":198661000.0,"ShortTermInvestments_0_Q3_USD":19956000.0,"ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_0_Q3_shares":13162504.0,"ShareBasedCompensation_3_Q3_USD":4601000.0,"ShareBasedCompensation_1_Q3_USD":1512000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":36401000.0,"PreferredStockValue_0_Q3_USD":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":4428000.0,"PrepaidInsurance_0_Q3_USD":231000.0,"PrepaidTaxes_0_Q3_USD":13000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":3414000.0,"ProfitLoss_3_Q3_USD":30173000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":223248000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":951000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":11944000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-32544000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":35954000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":102524000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":58000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":12153000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":4487000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":103196550.0,"Liabilities_0_Q3_USD":24587000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":506000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":30079000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":10303000.0,"CommonStockValue_0_Q3_USD":103000.0,"CommonStockSharesOutstanding_0_Q3_shares":103153459.0,"CommonStockSharesIssued_0_Q3_shares":103153459.0,"CommonStockSharesAuthorized_0_Q3_shares":200000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":24599000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":154836000.0,"AvailableForSaleSecuritiesGrossUnrealizedLoss_3_Q3_USD":63000.0,"AvailableForSaleSecuritiesGrossUnrealizedGains_3_Q3_USD":0.0,"AvailableForSaleSecuritiesGrossRealizedGainLossNet_3_Q3_USD":0.0,"AvailableForSaleSecuritiesGrossRealizedGainLossNet_1_Q3_USD":0.0,"CostOfGoodsAndServicesSold_1_Q3_USD":5310000.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q3_USD":125014000.0,"AssetsCurrent_0_Q3_USD":192795000.0,"Assets_0_Q3_USD":223248000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":5300000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":2600000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q3_USD":1380000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_1_Q3_USD":132000.0,"AdditionalPaidInCapital_0_Q3_USD":231165000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-63000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":242000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":1978000.0,"AccruedLiabilitiesCurrentAndNoncurrent_0_Q3_USD":21835000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":17862000.0,"AccruedIncomeTaxesCurrent_0_Q3_USD":335000.0,"AccountsReceivableNetCurrent_0_Q3_USD":6625000.0,"AvailableForSaleSecurities_0_Q3_USD":124951000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":14536000.0,"DeferredIncomeTaxAssetsNet_0_Q3_USD":26400000.0,"DepositsAssetsNoncurrent_0_Q3_USD":9000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":522000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":537000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":492000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":5287000.0,"LeaseAndRentalExpense_3_Q3_USD":300000.0,"LeaseAndRentalExpense_1_Q3_USD":100000.0,"InventoryWorkInProcessNetOfReserves_0_Q3_USD":4847000.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":1112000.0,"InventoryNet_0_Q3_USD":6950000.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":991000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-3900000.0,"IncreaseDecreaseInOperatingLeaseLiability_3_Q3_USD":942000.0,"IncreaseDecreaseInInventories_3_Q3_USD":2299000.0,"IncreaseDecreaseInDeferredIncomeTaxes_3_Q3_USD":-6571000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":-916000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":638000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-1504000.0,"Depreciation_3_Q3_USD":159000.0,"EarningsPerShareBasic_1_Q3_USD":0.1,"EarningsPerShareBasic_3_Q3_USD":0.29,"EarningsPerShareDiluted_1_Q3_USD":0.1,"EarningsPerShareDiluted_3_Q3_USD":0.28,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.243,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":1036000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q3_pure":0.21,"FinanceLeaseLiability_0_Q3_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":14072000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":39854000.0,"IncomeTaxesPaid_3_Q3_USD":1438000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":3743000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":9681000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":2647000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":103470762.0,"Ticker":"CPRX","CIK":"1369568","name":"CATALYST PHARMACEUTICALS, INC.","OfficialName":"Catalyst Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"872304311.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211109"}]